PT - JOURNAL ARTICLE AU - A.C. Mahasinghe AU - K.K.W.H. Erandi AU - S.S.N. Perera TI - An optimal lockdown relaxation strategy for minimizing the economic effects of covid–19 outbreak AID - 10.1101/2020.06.08.20125583 DP - 2021 Jan 01 TA - medRxiv PG - 2020.06.08.20125583 4099 - http://medrxiv.org/content/early/2021/01/21/2020.06.08.20125583.short 4100 - http://medrxiv.org/content/early/2021/01/21/2020.06.08.20125583.full AB - In order to recover the damage to the economy by the ongoing covid–19 pandemic, many countries consider the transition from strict lockdowns to partial lockdowns through relaxation of preventive measures. In this work, we propose an optimal lockdown relaxation strategy, which is aimed at minimizing the damage to the economy, while confining the covid–19 incidence to a level endurable by the available healthcare facilities in the country. In order to capture the transmission dynamics, we adopt the compartment models and develop the relevant optimization model, which turns out to be non–linear. We generate approximate solutions to the problem, whereas our experimentation is based on the data on the covid–19 outbreak in Sri Lanka.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was partly supported by the National Science Foundation (grant no. RPHS/2016/D/05)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All relevant ethical guidelines have been followedAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCOVID–19 data can be retrieved via Epidemiology Unit, Ministry of Health, Sri Lanka, Available at:http://www.epid.gov.lk/web/index.php?option=comcontent&view=article&id=225&Itemid=518&lang=en and mobility data can be retrieved via National Transport Commission, Sri Lanka, Available at: https://www.ntc.gov.lk/corporate/pdf/statistics%202015.pdf